Singapore markets close in 6 minutes
Straits Times Index
3,144.45 +4.24 (+0.14%) Nikkei
26,804.60 -244.87 (-0.91%) Hang Seng
21,996.89 -422.08 (-1.88%) FTSE 100
7,287.25 -36.16 (-0.49%) BTC-USD
20,042.61 -997.48 (-4.74%) CMC Crypto 200
433.68 -16.38 (-3.64%)
Precision BioSciences, Inc. (DTIL)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
| Previous close | 1.7700 |
| Open | 1.7800 |
| Bid | 0.0000 x 2900 |
| Ask | 0.0000 x 3000 |
| Day's range | 1.5300 - 1.8500 |
| 52-week range | 1.1100 - 14.3800 |
| Volume | |
| Avg. volume | 2,258,935 |
| Market cap | 97.617M |
| Beta (5Y monthly) | 1.81 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Cybin (CYBN) Up on FDA Clearance of IND for CYB003 in MDD
Cybin (CYBN) receives a "may proceed letter" and IND application clearance from the FDA for a phase I/IIa study evaluating CYB003 for potential treatment of major depressive disorder. Shares up.
- Zacks
Novartis (NVS) Gets Positive CHMP Opinion for Scemblix in CML
The CHMP recommends approval of Novartis' (NVS) Scemblix for treating adult patients with chronic myeloid leukemia. EU also approves label expansion of Cosentyx.
- Zacks
AbbVie's (ABBV) Rinvoq Gets CHMP Nod for New Indication
The CHMP recommends approval of AbbVie's (ABBV) Rinvoq for treating adults with active non-radiographic axial spondyloarthritis.
© 2022 Yahoo. All rights reserved.
